v3.26.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid- in-Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   186,114,948        
Beginning balance at Dec. 31, 2024 $ 318,542 $ 380,325 $ 59,856 $ (150,848) $ (3,597) $ 32,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) (25,387)     (24,243)   (1,144)
Contributions from non-controlling interest 6,502   5,045     1,457
Inventory transfers to non-controlling interest (1,053)         (1,053)
Shares issued for exercise of stock options (in shares)   181,333        
Shares issued for exercise of stock options 141 $ 241 (100)      
Shares issued for exercise of warrants (in shares)   90,000        
Shares issued for exercise of warrants 236 $ 302 (66)      
Share-based compensation 878   878      
Cumulative translation adjustment 65       65  
Ending balance (in shares) at Mar. 31, 2025   186,386,281        
Ending balance at Mar. 31, 2025 299,924 $ 380,868 65,613 (175,091) (3,532) 32,066
Beginning balance (in shares) at Dec. 31, 2024   186,114,948        
Beginning balance at Dec. 31, 2024 318,542 $ 380,325 59,856 (150,848) (3,597) 32,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) (34,222)          
Shares issued for exercise of stock options (in shares)   853,376        
Shares issued for exercise of stock options 690   (544)      
Cumulative translation adjustment 1,329          
Ending balance (in shares) at Jun. 30, 2025   187,058,324        
Ending balance at Jun. 30, 2025 294,919 $ 381,861 66,500 (181,417) (2,268) 30,243
Beginning balance (in shares) at Mar. 31, 2025   186,386,281        
Beginning balance at Mar. 31, 2025 299,924 $ 380,868 65,613 (175,091) (3,532) 32,066
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) (8,835)     (6,326)   (2,509)
Contributions from non-controlling interest 2,773   580     2,193
Inventory transfers to non-controlling interest (1,507)         (1,507)
Shares issued for exercise of stock options (in shares)   672,043        
Shares issued for exercise of stock options 549 $ 993 (444)      
Share-based compensation 751   751      
Cumulative translation adjustment 1,264       1,264  
Ending balance (in shares) at Jun. 30, 2025   187,058,324        
Ending balance at Jun. 30, 2025 $ 294,919 $ 381,861 66,500 (181,417) (2,268) 30,243
Beginning balance (in shares) at Dec. 31, 2025 187,354,424 187,354,424        
Beginning balance at Dec. 31, 2025 $ 258,380 $ 382,842 56,733 (207,704) (2,626) 29,135
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) 2,513     5,404   (2,891)
Contributions from non-controlling interest 1,756         1,756
Inventory transfers to non-controlling interest (1,579)         (1,579)
Shares issued for exercise of warrants (in shares)   6,786,495        
Shares issued for exercise of warrants 17,798 $ 26,465 (8,667)      
Shares issued for exercise of stock options (in shares)   75,234        
Shares issued for exercise of stock options 149 $ 260 (111)      
Share-based compensation 2,374   2,374      
Cumulative translation adjustment (191)       (191)  
Ending balance (in shares) at Mar. 31, 2026   194,216,153        
Ending balance at Mar. 31, 2026 $ 281,200 $ 409,567 50,329 (202,300) (2,817) 26,421
Beginning balance (in shares) at Dec. 31, 2025 187,354,424 187,354,424        
Beginning balance at Dec. 31, 2025 $ 258,380 $ 382,842 56,733 (207,704) (2,626) 29,135
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) $ (42,101)          
Shares issued for exercise of warrants (in shares)   6,786,495        
Shares issued for exercise of stock options (in shares) 75,234 75,234        
Shares issued for exercise of stock options   $ 149 (111)      
Shares issued for restricted stock units (in shares)   34,446        
Shares issued for restricted stock units     (58)      
Cumulative translation adjustment $ 6,196          
Ending balance (in shares) at Jun. 30, 2026 194,250,599 194,250,599        
Ending balance at Jun. 30, 2026 $ 245,172 $ 409,625 52,472 (243,748) 3,570 23,253
Beginning balance (in shares) at Mar. 31, 2026   194,216,153        
Beginning balance at Mar. 31, 2026 281,200 $ 409,567 50,329 (202,300) (2,817) 26,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income ( loss) (44,614)     (41,448)   (3,166)
Contributions from non-controlling interest 646         646
Inventory transfers to non-controlling interest (648)         (648)
Shares issued for restricted stock units (in shares)   34,446        
Shares issued for restricted stock units 0 $ 58 (58)      
Share-based compensation 2,201   2,201      
Cumulative translation adjustment $ 6,387       6,387  
Ending balance (in shares) at Jun. 30, 2026 194,250,599 194,250,599        
Ending balance at Jun. 30, 2026 $ 245,172 $ 409,625 $ 52,472 $ (243,748) $ 3,570 $ 23,253